499 related articles for article (PubMed ID: 22665815)
21. Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.
Gagne JJ; Choudhry NK; Kesselheim AS; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
Ann Intern Med; 2014 Sep; 161(6):400-7. PubMed ID: 25222387
[TBL] [Abstract][Full Text] [Related]
22. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
23. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
[TBL] [Abstract][Full Text] [Related]
24. Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries - United States, 2014.
Ritchey M; Chang A; Powers C; Loustalot F; Schieb L; Ketcham M; Durthaler J; Hong Y
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(36):967-76. PubMed ID: 27632693
[TBL] [Abstract][Full Text] [Related]
25. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
[TBL] [Abstract][Full Text] [Related]
26. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries.
Holmes HM; Luo R; Hanlon JT; Elting LS; Suarez-Almazor M; Goodwin JS
J Am Geriatr Soc; 2012 Jul; 60(7):1298-303. PubMed ID: 22702464
[TBL] [Abstract][Full Text] [Related]
27. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
Raebel MA; Delate T; Ellis JL; Bayliss EA
Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
[TBL] [Abstract][Full Text] [Related]
28. Economic grand rounds: did Medicare Part D improve access to medications?
Domino ME; Farley JF
Psychiatr Serv; 2010 Feb; 61(2):118-20. PubMed ID: 20123814
[TBL] [Abstract][Full Text] [Related]
29. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
30. The doughnut hole: it's about medication adherence.
Roumie CL
Ann Intern Med; 2012 Jun; 156(11):834-5. PubMed ID: 22665817
[No Abstract] [Full Text] [Related]
31. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
Maciejewski ML; Bryson CL; Perkins M; Blough DK; Cunningham FE; Fortney JC; Krein SL; Stroupe KT; Sharp ND; Liu CF
Am J Manag Care; 2010 Jan; 16(1):e20-34. PubMed ID: 20059288
[TBL] [Abstract][Full Text] [Related]
32. Impact of a value-based formulary in three chronic disease cohorts.
Yeung K; Basu A; Marcum ZA; Watkins JB; Sullivan SD
Am J Manag Care; 2017 Mar; 23(3 Suppl):S46-S53. PubMed ID: 29648740
[TBL] [Abstract][Full Text] [Related]
33. Effect of generic-only drug benefits on seniors' medication use and financial burden.
Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
[TBL] [Abstract][Full Text] [Related]
34. Generic initiation and antidepressant therapy adherence under Medicare Part D.
Bao Y; Ryan AM; Shao H; Pincus HA; Donohue JM
Am J Manag Care; 2013 Dec; 19(12):989-98. PubMed ID: 24512035
[TBL] [Abstract][Full Text] [Related]
35. National Rates of Nonadherence to Antihypertensive Medications Among Insured Adults With Hypertension, 2015.
Chang TE; Ritchey MD; Park S; Chang A; Odom EC; Durthaler J; Jackson SL; Loustalot F
Hypertension; 2019 Dec; 74(6):1324-1332. PubMed ID: 31679429
[TBL] [Abstract][Full Text] [Related]
36. Assessment of drug consumption patterns for Medicare Part D patients.
Pedan A; Lu J; Varasteh LT
Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
[TBL] [Abstract][Full Text] [Related]
37. Geographic variation in medication adherence in commercial and Medicare part D populations.
Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
[TBL] [Abstract][Full Text] [Related]
38. The Medicare Part D doughnut hole: effect on pharmacy utilization.
Sun SX; Lee KY
Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
[TBL] [Abstract][Full Text] [Related]
40. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.
Chapman RH; Petrilla AA; Benner JS; Schwartz JS; Tang SS
Drugs Aging; 2008; 25(10):885-92. PubMed ID: 18808213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
